The Maximum Standardized Uptake Values on Integrated FDG-PET/CT Is Useful in Differentiating Benign From Malignant Pulmonary Nodules

Annals of Thoracic Surgery

Volumn 82, Issue 3, 2006, Pages 1016-1020

  Bryant, Ayesha S ^a   Cerfolio, Robert James ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CARCINOID; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; KIDNEY CELL; LUNG ALVEOLUS CELL CARCINOMA; LUNG NODULE; LUNG TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MYCOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR BIOPSY; TUMOR VOLUME;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; CARCINOID TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, RENAL CELL; COIN LESION, PULMONARY; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FROZEN SECTIONS; HUMANS; LUNG DISEASES; LUNG DISEASES, FUNGAL; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THORACIC SURGERY, VIDEO-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33747368466     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.03.095     Document Type: Article

References (10)

1. Cerfolio R.J., Bryant A.S., Ojha B., et al. Improving the inaccuracies of clinical staging of patients with NSCLC. a prospective trial. Ann Thorac Surg 80 (2005) 1207-1214
2. Nabi H.A., and Zubeldia J.M. Clinical applications of F18-FDG in Oncology. J Nucl Med Technol 30 (2002) 3-9
3. Mountain C.F. Revisions in the international staging system for lung cancer. Chest 111 (1997) 1710-1717
4. Bryant A.S., Cerfolio R.J., Klemm K.M., and Ojha B. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer. Ann Thorac Surg 82 (2006) 417-423
5. Dewan N.A., Shehan C.J., Reeb S.D., Gobar L.S., Scott W.J., and Ryschon K. Likelihood of malignancy in a solitary pulmonary nodule. comparison of Bayesian analysis and results of FGD-PET/CT scan. Chest 112 (1997) 416-422
6. Herder G.J., van T., Golding P.R., et al. Clinical prediction model to characterize pulmonary nodules. validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 128 (2005) 2490-2496
7. Nomori H., Watanabe K., Ohtsuka T., Naruke T., Suemasu K., and Uno K. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann Thorac Surg 79 (2005) 984-989
8. Kernstine K.H., Grannis F.W., and Rotter A.J. Is there a role for PET in the evaluation of subcentimeter pulmonary nodules?. Semin Thorac Cardiovasc Surg 17 (2005) 110-114
9. Nomori H., Watanabe K., Ohtsuka T., Naruke T., Suemasu K., and Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer 45 (2004) 29-30
10. Imdahl A., Jenkner S., Brink I., et al. Validation of FDG-positron emission tomography for differentiation of unknown pulmonary lesions. Eur J Cardiothorac Surg 20 (2001) 324-329